may result in market up by high-single-digits in 2014. Weight-loss stocks [ WTW, NTRI ] and diet-drug stocks [ VYUS, ARNA ] have been hit with company specific issues [ the obesity problem hasn’t gone away after all ] but they may not have bottomed
Arena Pharmaceuticals ' future depends on its late-stage obesity drug.
Jan 22 (Reuters) - Arena Pharmaceuticals Inc said the European health regulator had raised concerns with the company's obesity drug, Belviq, sending its shares down as much as 10 percent.
appearing to rebound, it’s little wonder that Ellie Mae has found strong demand for its product. Arena Pharma (NASDAQ: ARNA ): is up roughly 367 percent in 2012. It’s been overshadowed in the biotech world by Sarepta, but more than tripling in a single
(Reuters) - Health insurer Aetna Inc said it would provide coverage for diet pills of Vivus Inc and Arena Pharmaceuticals Inc , sending the obesity drugmakers' shares up.
(Reuters) - Health insurer Aetna Inc said it would provide coverage for Vivus Inc's and Arena Pharmaceuticals Inc's diet pills, sending the obesity drugmakers's shares up.
Opportunities Fund nor the Perritt Ultra MicroCap fund held a position in Pharmacyclics Inc. (PCYC), Arena Pharmaceuticals , Inc. ( ARNA ), Home Depot (HD) or Inhibitex, Inc. (INHX). The Perritt MicroCap Opportunities Fund held a 1
NEW YORK/WASHINGTON (Reuters) - U.S. health regulators approved the first new weight-loss drug in 13 years, allowing Arena Pharmaceuticals Inc to bring its Belviq pill to market as public health...
(Reuters) - Shares of Arena Pharmaceuticals Inc fell 15 percent on Friday, days ahead of a key meeting at which U.S. regulators will rule on whether to approve its experimental weight-loss drug.
(Reuters) - Shares of Arena Pharmaceuticals Inc nearly doubled in value after a panel of experts recommended approval of the company's obesity pill, a big step towards making it the first new diet...